The DOI matches its Crossref record.
The Unified Dyskinesia Rating Scale: Presentation and clinimetric profile
Abstract
We developed and tested a rating scale aimed to capture the essential features of dyskinesia in Parkinson's disease (PD). Although several scales assess selected attributes of PD‐dyskinesias, no comprehensive rating tool exists. Available rating scales were evaluated by the investigators and patient focus groups. Modifications were finalized into the Unified Dyskinesia Rating Scale (UDysRS). The UDysRS has four parts: I: Historical Disability (patient perceptions) of On‐Dyskinesia impact (maximum 44 points); II: Historical Disability (patient perceptions) of Off‐Dystonia impact (maximum 16 points); III: Objective Impairment (dyskinesia severity, anatomical distribution over seven body regions, and type (choreic or dystonic) based on four activities observed or video‐recorded (28 points); IV: Objective Disability based on Part III activities (maximum 16 points). For clinimetric testing, 70 PD patients with all severities of dyskinesia were interviewed and videotaped. Twenty movement disorder experts rated the videotapes with the UDysRS. Internal consistency was examined with Cronbach's alpha. Inter‐ and intra‐rater reliability was evaluated with generalized weighted and nonweighted Kappa coefficients, and intraclass correlation coefficients. Both subjective (Sections I and II) and objective (Sections III and IV) demonstrated high internal consistency (alpha: 0.915, 0.971). Interrater reliability for the objective sections was acceptable for all items and likewise for intrarater reliability except for right leg. Reliable factor structures were found for both subjective (six factors) and objective sections (five factors). The UDysRS is a clinimetrically sound rating scale for dyskinesia in PD, demonstrating acceptable levels of internal consistency and inter‐ and intra‐rater reliability. Testing scale responsivity to treatment interventions is planned. © 2008 Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 23
- 10.1002/mds.21475 · DOI · Paper page
- 10.1016/S1353-8020(01)00024-4 · DOI
- 10.1038/ncpneuro0340 · DOI
- 10.1038/35086062 · DOI · Paper page
- 10.1002/mds.1143 · DOI
- Johnston TH, 2006, Drugs in development for Parkinson's disease: an update, Curr Opin Investig Drug, 7, 25
- 10.1212/01.WNL.0000110317.52453.6C · DOI · Paper page
- Goetz CG, 1999, Rating scales for dyskinesias in Parkinson's disease, Mov Disord, 14, 48
- Guy W, 1976, AIMS: ECDEU assessment manual for psychopharmacology
- 10.1002/mds.870090403 · DOI · Paper page
- 10.1001/archneur.58.10.1660 · DOI
- Obeso JA, 1989, Motor complications associated with chronic levodopa‐therapy in Parkinson's disease, Neurology, 39, 11
- Langston JW, 1991, Intracerebral transplantation in movement disorders, 227
- 10.1002/1531-8257(199907)14:4<572::AID-MDS1005>3.0.CO;2-C · DOI · Paper page
- 10.1002/mds.20248 · DOI · Paper page
- 10.1212/01.wnl.0000310812.43352.66 · DOI · Paper page
- Nutt J, 1999, A Unified Dyskinesia Rating Scale for L‐dopa‐induced dyskinesias?, Mov Disord, 14, 74
- 10.1002/mds.21198 · DOI · Paper page
- 10.1136/bmj.328.7441.702 · DOI · Paper page
- Hauser RA, 2006, Patient evaluation of a home diary to assess duration and severity of dyskinesia in Parkinson's disease, Mov Disord, 29, 322
- 10.1002/mds.870120631 · DOI
- 10.1016/S0197-2456(02)00320-3 · DOI · Paper page
- 10.1002/mds.870100305 · DOI
Cited by
Priorities in Parkinson's disease research
Meissner, W. G., Frasier, M., Gasser, T., Goetz, C. G., Lozano, A., Piccini, P., Obeso, J. A., Rascol, O., Schapira, A., Voon, V., et al. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3430 · Cited by 436
Self-citationAdaptive deep brain stimulation for Parkinson’s disease using motor cortex sensing
Swann, N. C., de Hemptinne, C., Thompson, M. C., Miocinovic, S., Miller, A. M., Gilron, R., Ostrem, J. L., Chizeck, H. J., & Starr, P. A. (2018) · Journal of Neural Engineering · doi:10.1088/1741-2552/aabc9b · Cited by 389
Mak, E., Su, L., Williams, G. B., Firbank, M. J., Lawson, R. A., Yarnall, A. J., Duncan, G. W., Owen, A. M., Khoo, T. K., Brooks, D. J., et al. (2015) · Brain · doi:10.1093/brain/awv211 · Cited by 260
Clinimetrics: the science of clinical measurements
Fava, G. A., Tomba, E., & Sonino, N. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2011.02825.x · Cited by 233
Wearable sensor-based objective assessment of motor symptoms in Parkinson’s disease
Ossig, C., Antonini, A., Buhmann, C., Classen, J., Csoti, I., Falkenburger, B., Schwarz, M., Winkler, J., & Storch, A. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-015-1439-8 · Cited by 164
Metadata
- Authors
- Goetz, C. G., Nutt, J. G., & Stebbins, G. T.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2008-11-21
- Volume
- 23
- Issue
- 16
- Pages
- 2398-2403
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2000113722
- Cited by
- 251
- References
- 0
- FWCI
- 3.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Funders
- Michael J. Fox Foundation
- EMD/Merck KGaA Pharmaceuticals
- Parkinson's Disease Foundation Research Center
- National Parkinson Disease Center of Excellence
- NIH
- Biogen Boehringer-Ingelheim
- Ceregene
- EMD Pharmaceuticals
- Impax
- I3 Research
- Juvantia
- Kiowa
- GlaxoSmith Kline
- Merck KGaA
- Merck and Co.
- Neurim
- Novartis
- Ovation
- Oxford Biomedica
- Schering-Plough
- Solstice Neuroscience
- Solvay
- Synergy/Intec
- Teva Pharmaceuticals
- Fragile X Foundation
- Kinetics Foundation
- Kinetics Fdn
- National Parkinson Foundation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Unified Dyskinesia Rating Scale: Presentation and clinimetric profile. https://app.cochat.ai/papers/10.1002/mds.22341
- The paper
- Goetz, C. G., Nutt, J. G., & Stebbins, G. T. (2008). The Unified Dyskinesia Rating Scale: Presentation and clinimetric profile. Movement Disorders. https://doi.org/10.1002/mds.22341
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.